Correlation Between Citigroup and Ondine Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Ondine Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Ondine Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Ondine Biomedical, you can compare the effects of market volatilities on Citigroup and Ondine Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Ondine Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Ondine Biomedical.

Diversification Opportunities for Citigroup and Ondine Biomedical

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Citigroup and Ondine is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Ondine Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ondine Biomedical and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Ondine Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ondine Biomedical has no effect on the direction of Citigroup i.e., Citigroup and Ondine Biomedical go up and down completely randomly.

Pair Corralation between Citigroup and Ondine Biomedical

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.29 times more return on investment than Ondine Biomedical. However, Citigroup is 3.39 times less risky than Ondine Biomedical. It trades about 0.08 of its potential returns per unit of risk. Ondine Biomedical is currently generating about -0.01 per unit of risk. If you would invest  4,558  in Citigroup on September 2, 2024 and sell it today you would earn a total of  2,529  from holding Citigroup or generate 55.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.67%
ValuesDaily Returns

Citigroup  vs.  Ondine Biomedical

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Ondine Biomedical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Citigroup and Ondine Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Ondine Biomedical

The main advantage of trading using opposite Citigroup and Ondine Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Ondine Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ondine Biomedical will offset losses from the drop in Ondine Biomedical's long position.
The idea behind Citigroup and Ondine Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios